参考文献/References:
[1] 李晓晓,梁亚萍,赵 涛,等.结核病患者422例耐药情况调查研究[J].陕西医学杂志,2020,49(2):250-253.
[2] Rock RB,Olin M,Baker CA,et al.Central nervous system tuberculosis:Pathogenesis and clinical aspects[J].Clinical Microbiology Reviews,2008,21(2):243-261.
[3] 孟艺哲,卜彩霞,陈颜强.不同剂量地塞米松联合异烟肼鞘内注射治疗结核性脑膜炎临床研究[J].陕西医学杂志,2017,46(12):1777-1778.
[4] Ho J,Marais BJ,Gilbert GL,et al.Diagnosing tuberculous meningitis have we made any progress? [J].Trop Med Int Heal,2013,18:783-793.
[5] Almeida SM,Furlan SMP,Cretella AMM,et al.Comparison of cerebrospinal fluid biomarkers for differential diagnosis of acute bacterial and viral meningitis with atypical cerebrospinal fluid characteristics[J].Med Princ Pract,2020,29:244-254.
[6] Thwaites GE,Chau TT,Farrar JJ.Improving the bacteriological diagnosis of tuberculous meningitis[J].Journal of Clinical Microbiology,2004,42(1):378-379.
[7] Wilkinson RJ,Rohlwink U,Misra UK,et al.Tuberculous meningitis[J].Nat Rev Neurol,2017,13(10):581-598.
[8] Mai NT,Thwaites GE.Recent advances in the diagnosis and management of tuberculous meningitis[J].Current Opinion in Infectious Diseases,2017,30(1):123-128.
[9] 李雪莲,马丽萍,陈红梅,等.脑脊液中腺苷脱氨酶水平对结核性脑膜炎的诊断价值[J].中华结核和呼吸杂志,2017,40(5):339-342.
[10] Marais S,Thwaites G,Schoeman JF,et al.Tuberculous meningitis:A uniform case definition for use in clinical research[J].Lancet Infect Dis,2010,10(11):803-812.
[11] 赵雁林,刘宇红,姜广路,等.中国结核病防治规划痰涂片镜检标准化操作及质量保证手册[M].北京:中国协和医科大学出版社,2008:1-51.
[12] 王黎霞.结核分枝杆菌药物敏感性试验标准化操作程序及质量保证手册[M].北京:人民卫生出版社,2013:1-40.
[13] Bahr NC,Marais S,Caws M,et al.GeneXpert MTB/Rif to diagnose tuberculous meningitis:Perhaps the First test but not the last[J].Clin Infect Dis,2016,62:1133-1135.
[14] Lekhak SP,Sharma L,Rajbhandari R,et al.Evaluation of multiplex PCR using MPB64 and IS6110 primers for rapid diagnosis of tuberculous meningitis[J].Tuberculosis,2016,100:1-4.
[15] Xu HB,Jiang RH,Li L,et al.Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis:A meta-analysis[J].Int J Tuberc Lung Dis,2010,14(11):1382-1387.
[16] Tuon FF,Higashino HR,Lopes MI,et al.Adeenosine deaminase and tuberculous meningitis:A systematic review with meta-analysis[J].Scand J Infect Dis,2010,42(3):198-207.
[17] Pormohammad A,Riahi SM,Nasiri MJ,et al.Diagnositc test accuracy of adenosine deaminase for tuber culous meningitis:A systematic review and meta-analysis[J].J Infect,2017,74(6):545-554.
[18] Moghtaderi A,Niazi A,Alavi-Naini R,et al.Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis[J].Clin Neurol Neurosurg,2010,112(6):459-462.
[19] 张苏宁,赵守松,崔 琢.30例结核性脑膜炎的临床特点及治疗[J].中华全科医学,2013,11(11):1734,1744.
[20] Fujiwara S,Mimura N,Yoshimura H,et al.Elevated adenosine deaminase levels in the cerebrospinal fluid in immune checkpoint inhibitor-induced autoimmune encephalitis[J].Intern Med,2019,58(19):2871-2874.
相似文献/References:
[1]王科文,吴胜波,马纪龙,等.三种方法联合检测诊断结核性胸腔积液60例临床研究*[J].陕西医学杂志,2020,49(10):1347.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.039]
[2]方 圆,赵 峰,陈 佩,等.胸腔积液结核分枝杆菌感染T细胞检测对结核性胸膜炎的诊断价值研究*[J].陕西医学杂志,2020,49(12):1681.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.038]
FANG Yuan,ZHAO Feng,CHEN Pei,et al.Value of T-SPOT.TB assay from pleural fIuid in diagnosis of tuberculous pleurisy[J].,2020,49(3):1681.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.038]
[3]杨 翰,李爱芳,张永峰,等.结核性脑膜炎分子诊断研究进展[J].陕西医学杂志,2021,50(11):1457.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.034]